Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.

[This corrects the article DOI: 10.1371/journal.pone.0245481.].

Guardado en:

Detalles Bibliográficos
Autores principales:	Ji Bak Kim, Woo Hyuk Song, Jong Sung Park, Tae-Jin Youn, Yong Hyun Park, Shin-Jae Kim, Sung Gyun Ahn, Joon-Hyung Doh, Yun-Hyeong Cho, Jin Won Kim
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/9350a809b1d84ea5af95fe89f43132b7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9350a809b1d84ea5af95fe89f43132b7
record_format	dspace
spelling	oai:doaj.org-article:9350a809b1d84ea5af95fe89f43132b72021-11-25T06:23:19ZCorrection: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.1932-620310.1371/journal.pone.0259072https://doaj.org/article/9350a809b1d84ea5af95fe89f43132b72021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0259072https://doaj.org/toc/1932-6203[This corrects the article DOI: 10.1371/journal.pone.0245481.].Ji Bak KimWoo Hyuk SongJong Sung ParkTae-Jin YounYong Hyun ParkShin-Jae KimSung Gyun AhnJoon-Hyung DohYun-Hyeong ChoJin Won KimPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 10, p e0259072 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Ji Bak Kim Woo Hyuk Song Jong Sung Park Tae-Jin Youn Yong Hyun Park Shin-Jae Kim Sung Gyun Ahn Joon-Hyung Doh Yun-Hyeong Cho Jin Won Kim Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
description	[This corrects the article DOI: 10.1371/journal.pone.0245481.].
format	article
author	Ji Bak Kim Woo Hyuk Song Jong Sung Park Tae-Jin Youn Yong Hyun Park Shin-Jae Kim Sung Gyun Ahn Joon-Hyung Doh Yun-Hyeong Cho Jin Won Kim
author_facet	Ji Bak Kim Woo Hyuk Song Jong Sung Park Tae-Jin Youn Yong Hyun Park Shin-Jae Kim Sung Gyun Ahn Joon-Hyung Doh Yun-Hyeong Cho Jin Won Kim
author_sort	Ji Bak Kim
title	Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
title_short	Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
title_full	Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
title_fullStr	Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
title_full_unstemmed	Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
title_sort	correction: a randomized, open-label, parallel, multi-center phase iv study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk asian patients with hypercholesterolemia.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/9350a809b1d84ea5af95fe89f43132b7
work_keys_str_mv	AT jibakkim correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT woohyuksong correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT jongsungpark correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT taejinyoun correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT yonghyunpark correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT shinjaekim correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT sunggyunahn correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT joonhyungdoh correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT yunhyeongcho correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia AT jinwonkim correctionarandomizedopenlabelparallelmulticenterphaseivstudytocomparetheefficacyandsafetyofatorvastatin10and20mginhighriskasianpatientswithhypercholesterolemia
_version_	1718413814145220608

Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.

Ejemplares similares